Foyston, Gordon, & Payne’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.3M | Sell |
|
|||||
2025
Q1 | $1.21M | Sell |
|
|||||
2024
Q4 | $1.07M | Buy |
|
|||||
2024
Q3 | $1.25M | Sell |
|
|||||
2024
Q2 | $2.54M | Sell |
|
|||||
2024
Q1 | $2.41M | Sell |
|
|||||
2023
Q4 | $2.57M | Buy |
|
|||||
2023
Q3 | $1.05M | Sell |
|
|||||
2023
Q2 | $11.4M | Buy |
|
|||||
2023
Q1 | $2.7M | Sell |
|
|||||
2022
Q4 | $2.72M | Sell |
|
|||||
2022
Q3 | $2.33M | Buy |
|
|||||
2022
Q2 | $2.69M | Sell |
|
|||||
2022
Q1 | $2.78M | Buy |
|
|||||
2021
Q4 | $2.77M | Sell |
|
|||||
2021
Q3 | $3.54M | Sell |
|
|||||
2021
Q2 | $3.97M | Sell |
|
|||||
2021
Q1 | $4.82M | Sell |
|
|||||
2020
Q4 | $5.41M | Sell |
|
|||||
2020
Q3 | $5.24M | Buy |
|
|||||
2020
Q2 | $5.13M | Sell |
|
|||||
2020
Q1 | $5.82M | Sell |
|
|||||
2019
Q4 | $6.86M | Buy |
|
|||||
2019
Q3 | $6.12M | Sell |
|
|||||
2019
Q2 | $7.36M | Sell |
|
|||||
2019
Q1 | $7.74M | Sell |
|
|||||
2018
Q4 | $6.91M | Sell |
|
|||||
2018
Q3 | $7.55M | Buy |
|
|||||
2018
Q2 | $6.57M | Buy |
|
|||||
2018
Q1 | $6.8M | Sell |
|
|||||
2017
Q4 | $7.12M | Sell |
|
|||||
2017
Q3 | $14.4M | Buy |
|
|||||
2017
Q2 | $7.26M | Sell |
|
|||||
2017
Q1 | $6.58M | Sell |
|
|||||
2016
Q4 | $6.66M | Buy |
|
|||||
2016
Q3 | $640K | Hold |
|
|||||
2016
Q2 | $668K | Hold |
|
|||||
2016
Q1 | $587K | Sell |
|
|||||
2015
Q4 | $703K | Hold |
|
|||||
2015
Q3 | $751K | Buy |
|
|||||
2015
Q2 | $797K | Hold |
|
|||||
2015
Q1 | $799K | Hold |
|
|||||
2014
Q4 | $751K | Hold |
|
|||||
2014
Q3 | $762K | Sell |
|
|||||
2014
Q2 | $757K | Hold |
|
|||||
2014
Q1 | $711K | Sell |
|
|||||
2013
Q4 | $693K | Hold |
|
|||||
2013
Q3 | $661K | Buy |
|